COST-EFFECTIVENESS OF TOCILIZUMAB MONOTHERAPY VERSUS ADALIMUMAB MONOTHERAPY IN THE TREATMENT OF SEVERE ACTIVE RA

被引：0
|
作者：
Carlson, J. J. [1 ]
Ogale, S. [2 ]
Dejonckheere, F. [3 ]
Sullivan, S. D. [1 ]
机构：
[1] Univ Washington, Seattle, WA 98195 USA
[2] Genentech Inc, San Francisco, CA 94080 USA
[3] F Hoffmann La Roche Ltd, Basel, Switzerland
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
10.1016/j.jval.2012.08.1398
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A447 / A447
页数：1
相关论文
共 50 条
  • [21] COST-EFFECTIVENESS OF ATEZOLIZUMAB MONOTHERAPY VERSUS PEMBROLIZUMAB MONOTHERAPY FOR FIRST-LINE TREATMENT OF METASTATIC NON-SMALL CELL LUNG CANCER
    Lin, C. W.
    Rosettie, K.
    Bilir, S. P.
    Celik, H.
    Abogunrin, S.
    Ogale, S.
    [J]. VALUE IN HEALTH, 2021, 24 : S37 - S37
  • [22] COST-EFFECTIVENESS OF CERTOLIZUMAB PEGOL PLUS METHOTREXATE OR AS MONOTHERAPY FOR THE TREATMENT OF ACTIVE RHEUMATOID ARTHRITIS IN THE UNITED KINGDOM
    Purcaru, O.
    Taylor, P. C.
    Emery, P.
    Palmer, S.
    [J]. VALUE IN HEALTH, 2010, 13 (07) : A310 - A310
  • [23] Cost-effectiveness analysis of etanercept monotherapy versus infliximab plus methotrexate in the treatment of rheumatoid arthritis.
    Malone, DC
    [J]. ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S322 - S322
  • [24] Economic Evaluation of Rheumathoid Arthritis Monotherapy with Tocilizumab and Adalimumab
    Navarro Sarabia, Federico
    Blanco, Francisco J.
    Alvaro Gracia, Jose Ma
    Gracia Meijide, Juan A.
    Luis Poveda, Jose
    Rubio-Rodriguez, Dario
    Rubio-Terres, Carlos
    [J]. REVISTA ESPANOLA DE SALUD PUBLICA, 2013, 87 (04): : 343 - 350
  • [25] Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study
    Jones, G.
    Sebba, A.
    Gu, J.
    Lowenstein, M. B.
    Calvo, A.
    Gomez-Reino, J. J.
    Siri, D. A.
    Tomsic, M.
    Alecock, E.
    Woodworth, T.
    Genovese, M. C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (01) : 88 - 96
  • [26] Cost-effectiveness of rosiglitazone monotherapy compared with glibenclamide monotherapy for treating Type 2 diabetes
    Beale, S
    Bagust, A
    Downs, KE
    Perry, AS
    [J]. DIABETOLOGIA, 2002, 45 : A301 - A301
  • [27] Cost-effectiveness of rosiglitazone monotherapy compared with glyburide monotherapy for treating type 2 diabetes
    Beale, S
    Bagust, A
    Downs, KE
    Perry, AS
    [J]. DIABETES, 2002, 51 : A270 - A270
  • [28] COST-EFFECTIVENESS ANALYSIS OF TOCILIZUMAB SUBCUTANEOUS AS FIRST LINE BIOLOGIC MONOTHERAPY FOR RHEUMATOID ARTHRITIS MANAGEMENT IN GREECE
    Athanasakis, K.
    Tarantilis, F.
    Skroumpelos, A.
    Kyriopoulos, J.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A671 - A671
  • [29] Cost-effectiveness of indapamide monotherapy in stroke prevention in Hungary
    Brodszky, V.
    Karpati, K.
    Majer, I.
    Nagy, V.
    Farsang, C.
    Gulacsi, L.
    [J]. JOURNAL OF HYPERTENSION, 2007, 25 : S222 - S222
  • [30] COMPARING COSTS PER CLINICAL REMISSION OF TOCILIZUMAB MONOTHERAPY VERSUS ADALIMUMAB MONOTHERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS: A BRAZILIAN PRIVATE PERSPECTIVE
    Buschinelli, C. T.
    Tsuchiya, C. T.
    Maximo, M. F. M.
    Tobaruella, F. S.
    Goncalves, T. M.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A716 - A716
12345